NCT00317486View on ClinicalTrials.gov

Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
Interventions
DRUG

bosentan

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY

NCT00317486 - Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology | Biotech Hunter | Biotech Hunter